★ WIDE MOAT STOCKS COMPARISON ★

Checking

Stock Comparison

Eli Lilly and Company vs Morningstar, Inc.

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

Eli Lilly and Company

LLY · New York Stock Exchange

Market cap (USD)$1T
Gross margin (TTM)83.5%
Operating margin (TTM)45.9%
Net margin (TTM)35%
SectorHealthcare
IndustryDrug Manufacturers - General
CountryUS
Data as of2026-07-12
Moat score
91/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Eli Lilly and Company's moat claims, evidence, and risks.

View LLY analysis

Morningstar, Inc.

MORN · NASDAQ

Market cap (USD)$6.2B
Gross margin (TTM)61.7%
Operating margin (TTM)22.7%
Net margin (TTM)16.1%
SectorFinancials
IndustryFinancial - Data & Stock Exchanges
CountryUS
Data as of2026-07-12
Moat score
67/ 100

Partial score covering 76% of segment weight.

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Morningstar, Inc.'s moat claims, evidence, and risks.

View MORN analysis

Comparison highlights

  • Segment focus: Eli Lilly and Company has 5 segments (79.6% in Cardiometabolic Health); Morningstar, Inc. has 7 segments (33.4% in Morningstar Direct Platform).
  • Primary market structure: Oligopoly vs Oligopoly. Pricing power: Strong vs Moderate.
  • Moat breadth: Eli Lilly and Company has 2 moat types across 2 domains; Morningstar, Inc. has 2 across 2.

Primary market context

Eli Lilly and Company

Cardiometabolic Health

Market

Cardiometabolic pharmaceuticals (diabetes, obesity, and related metabolic diseases)

Geography

Global (with U.S. as the largest market)

Customer

Patients via prescribers and payers (commercial/government)

Role

Branded drug developer/manufacturer

Revenue share

79.6%

Morningstar, Inc.

Morningstar Direct Platform

Market

Investment data, research, and analytics platforms

Geography

Global

Revenue share

33.4%

Side-by-side metrics

Eli Lilly and Company
Morningstar, Inc.
Ticker / Exchange
LLY - New York Stock Exchange
MORN - NASDAQ
Market cap (USD)
$1T
$6.2B
Gross margin (TTM)
83.5%
61.7%
Operating margin (TTM)
45.9%
22.7%
Net margin (TTM)
35%
16.1%
Sector
Healthcare
Financials
Industry
Drug Manufacturers - General
Financial - Data & Stock Exchanges
HQ country
US
US
Primary segment
Cardiometabolic Health
Morningstar Direct Platform
Market structure
Oligopoly
Oligopoly
Market share
n/a
n/a
HHI estimate
n/a
n/a
Pricing power
Strong
Moderate
Moat score
91 / 100
67 / 100 (partial, 76% coverage)
Moat domains
Legal, Supply
Demand, Legal
Last update
2026-07-12
2026-07-12

Moat coverage

Shared moat types

No overlap yet.

Eli Lilly and Company strengths

IP Choke PointCapacity Moat

Morningstar, Inc. strengths

Data Workflow LockinRegulated Standards Pipe

Segment mix

Eli Lilly and Company segments

Full profile >

Cardiometabolic Health

Oligopoly

79.6%

Oncology

Competitive

11.5%

Immunology

Oligopoly

6.1%

Neuroscience

Competitive

1.9%

Other

Competitive

0.9%

Morningstar, Inc. segments

Full profile >

Morningstar Direct Platform

Oligopoly

33.4%

PitchBook

Oligopoly

26.7%

Morningstar Credit

Oligopoly

15.7%

Morningstar Wealth

Competitive

9%

Morningstar Retirement

Competitive

6%

Morningstar Sustainalytics

Oligopoly

4.1%

Morningstar Indexes

Oligopoly

5.1%

Act on this comparison

Turn a two-stock debate into a systemSee the systematic rankings that surface stocks like LLY and MORN, with backtests and current holdings.

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Looking for expansion-stage stocks?

Proven models entering the expansion stage with unit economics that work.

View expansion-stage stocks

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.